Patents by Inventor Julie Pratt

Julie Pratt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8399402
    Abstract: The present invention provides a polypeptide as standard for peptide analysis by mass spectrometry comprising at least 16 peptides selected from the group consisting of the peptides of SEQ ID NO: 1 to SEQ ID NO: 22 or variants thereof, together with an artificial protein comprising the polypeptide, a vector comprising a nucleic acid encoding the polypeptide, a kit for proteome analysis, a selection of peptides for calibration an devaluation of mass spectrometers and chromatographs for proteome analysis and uses thereof.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: March 19, 2013
    Assignee: Polyquant GmbH
    Inventors: Robert Beynon, Simon Gaskell, Julie Pratt, Claire Eyers
  • Publication number: 20100197889
    Abstract: The present invention provides a polypeptide as standard for peptide analysis by mass spectrometry comprising at least 16 peptides selected from the group consisting of the peptides of SEQ ID NO: 1 to SEQ ID NO: 22 or variants thereof, together with an artificial protein comprising the polypeptide, a vector comprising a nucleic acid encoding the polypeptide, a kit for proteome analysis, a selection of peptides for calibration an devaluation of mass spectrometers and chromatographs for proteome analyses and uses thereof.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 5, 2010
    Applicant: POLYQUANT GMBH
    Inventors: Robert Beynon, Simon Gaskell, Julie Pratt, Claire Eyers
  • Publication number: 20080076709
    Abstract: This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.
    Type: Application
    Filed: January 25, 2007
    Publication date: March 27, 2008
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Michael Black, Martin Burnham, Jason Fedon, John Hodgson, David Knowles, Michael Lonetto, Richard Nicholas, Leslie Palmer, Julie Pratt, Raymond Reichard, Martin Rosenberg, Christopher Traini, Judith Ward, Richard Warren
  • Publication number: 20060083752
    Abstract: This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.
    Type: Application
    Filed: June 23, 2005
    Publication date: April 20, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Michael Black, Martin Burnham, Jason Fedon, John Hodgson, David Knowles, Michael Lonetto, Richard Nicholas, Leslie Palmer, Julie Pratt, Raymond Reichard, Martin Rosenberg, Christopher Traini, Judith Ward, Richard Warren